R. Firth

发表

Cognitive therapy for irritable bowel syndrome is associated with reduced limbic activity, GI symptoms, and anxiety.

A. Lockwood, D. Wack, J. Lackner, 2006, Behaviour research and therapy.

The accuracy of patient‐reported measures for GI symptoms: a comparison of real time and retrospective reports

J. Jaccard, J. Lackner, L. Keefer, 2014, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Patient-reported outcomes for irritable bowel syndrome are associated with patients' severity ratings of gastrointestinal symptoms and psychological factors.

J. Jaccard, J. Lackner, L. Katz, 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Proactive Screening for Psychosocial Risk Factors in Moderate to Severe Patients with Irritable Bowel Syndrome: the Predictive Validity of the Rome III Psychosocial Alarm Questionnaire

J. Lackner, G. Gudleski, M. Sitrin, 2012 .

A controlled evaluation of group cognitive therapy in the treatment of irritable bowel syndrome.

E. Blanchard, J. Lackner, L. Keefer, 2007, Behaviour research and therapy.

Study protocol and methods for Easing Pelvic Pain Interventions Clinical Research Program (EPPIC): a randomized clinical trial of brief, low-intensity, transdiagnostic cognitive behavioral therapy vs education/support for urologic chronic pelvic pain syndrome (UCPPS)

J. Jaccard, B. Naliboff, B. Quigley, 2022, Trials.

Comparing Patient and Provider Experiences with Atrial Fibrillation to Highlight Gaps and Opportunities for Improving Care

A. Curtis, B. Quigley, J. Lackner, 2022, Journal of General Internal Medicine.

Type, rather than number, of mental and physical comorbidities increases the severity of symptoms in patients with irritable bowel syndrome.

B. Naliboff, E. Mayer, J. Lackner, 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Negative aspects of close relationships are more strongly associated than supportive personal relationships with illness burden of irritable bowel syndrome.

J. Lackner, L. Keefer, G. Gudleski, 2013, Journal of Psychosomatic Research.

The Irritable Bowel Syndrome Outcome Study (IBSOS): rationale and design of a randomized, placebo-controlled trial with 12 month follow up of self- versus clinician-administered CBT for moderate to severe irritable bowel syndrome.

J. Jaccard, J. Lackner, L. Keefer, 2012, Contemporary clinical trials.

Correlates of Body Mass Index in Moderate to Severe Irritable Bowel Syndrome Patients

B. Quigley, J. Lackner, G. Gudleski, 2018 .

Improvement in Gastrointestinal Symptoms After Cognitive Behavior Therapy for Refractory Irritable Bowel Syndrome.

J. Jaccard, J. Lackner, L. Keefer, 2018, Gastroenterology.

Cognitive behavioral therapy for irritable bowel syndrome induces bidirectional alterations in the brain-gut-microbiome axis associated with gastrointestinal symptom improvement

B. Ellingson, B. Naliboff, E. Mayer, 2021, Microbiome.

Cognitive behavioral therapy for irritable bowel syndrome induces bidirectional alterations in the brain-gut-microbiome axis associated with gastrointestinal symptom improvement

B. Ellingson, B. Naliboff, E. Mayer, 2021, Microbiome.

Durability and Decay of Treatment Benefit of Cognitive Behavioral Therapy for Irritable Bowel Syndrome: 12-Month Follow-Up

J. Jaccard, J. Lackner, L. Keefer, 2018, The American Journal of Gastroenterology.